InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Hashim Mir, Directeur Scientifique. Officer active across 1 companies, notably Rani Therapeutics Holdings, Inc.. In total, 3 disclosures have been logged. The latest transaction was filed on 22 March 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations3 total
041,200 shares0
Class A Common Stock
SEC:0001209191-22-021018:0·
0117,600 shares0
Class A Common Stock
SEC:0001209191-21-055764·
0117,600 shares0
Class A Common Stock
SEC:0001209191-21-055764:0·
3 of 3 declarations
About Hashim Mir
Mir Hashim is the Chief Scientific Officer at Rani Therapeutics Holdings, Inc. He is responsible for leading the company's research and development efforts. With expertise in scientific fields, he plays a crucial role in innovation and the development of new therapies. Mir Hashim is committed to advancing the company's mission by providing cutting-edge therapeutic solutions.
